Antibody-based therapeutics
- PMID: 30771882
- DOI: 10.1016/j.dmpk.2019.01.006
Antibody-based therapeutics
Similar articles
-
Monoclonal antibody therapeutics: history and future.Curr Opin Pharmacol. 2012 Oct;12(5):615-22. doi: 10.1016/j.coph.2012.08.001. Epub 2012 Aug 21. Curr Opin Pharmacol. 2012. PMID: 22920732 Review.
-
Potent antibody therapeutics by design.Nat Rev Immunol. 2006 May;6(5):343-57. doi: 10.1038/nri1837. Nat Rev Immunol. 2006. PMID: 16622479 Review.
-
Computer-Aided Antibody Design: An Overview.Adv Exp Med Biol. 2017;1053:221-243. doi: 10.1007/978-3-319-72077-7_11. Adv Exp Med Biol. 2017. PMID: 29549642 Review.
-
[Pharmacokinetic monitoring as a new tool to individualize anti-TNF therapy].Farm Hosp. 2014 Apr 1;38(2):83-5. Farm Hosp. 2014. PMID: 24669890 Spanish.
-
Pharmacokinetic considerations of antibody therapeutics.Biopharm Drug Dispos. 2016 Mar;37(2):49-50. doi: 10.1002/bdd.2002. Biopharm Drug Dispos. 2016. PMID: 27028107 No abstract available.
Cited by
-
Multiphysics Modeling and Simulation of Subcutaneous Injection and Absorption of Biotherapeutics: Model Development.Pharm Res. 2021 Apr;38(4):607-624. doi: 10.1007/s11095-021-03032-w. Epub 2021 Apr 2. Pharm Res. 2021. PMID: 33811278
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources